Yiting Bao
Overview
Explore the profile of Yiting Bao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang M, Mo J, Huang W, Bao Y, Luo X, Yuan L
Front Cell Infect Microbiol
. 2024 Nov;
14:1440742.
PMID: 39497925
A growing body of research has established a correlation between tumors and persistent chronic inflammatory infiltration. As a primary instigator of inflammation, the majority of microbiomes naturally residing within our...
2.
Wang R, Li H, Han L, Han B, Bao Y, Fan H, et al.
Front Bioeng Biotechnol
. 2024 Feb;
12:1361966.
PMID: 38410166
The mitochondria act as the main producers of reactive oxygen species (ROS) within cells. Elevated levels of ROS can activate the mitochondrial apoptotic pathway, leading to cell apoptosis. In this...
3.
Luo X, Mo J, Zhang M, Huang W, Bao Y, Zou R, et al.
World J Surg Oncol
. 2024 Feb;
22(1):44.
PMID: 38317230
Background: Epithelial ovarian cancer (EOC) is insensitive to immunotherapy due to its poor immunogenicity; thus, suitable biomarkers need to be identified for better prognostic stratification and individualized treatment. CD47 is...
4.
Bao Y, Zhang H, Huang W, Luo X, Yao L, Feng G, et al.
Arch Gynecol Obstet
. 2023 Sep;
309(4):1483-1490.
PMID: 37695371
Purpose: To elucidate the clinicopathological features and prognostic factors of minimal deviation adenocarcinoma (MDA) of the uterine cervix, a clinically rare but highly invasive disease. Methods: This was a retrospective,...
5.
Huang W, Bao Y, Luo X, Yao L, Yuan L
J Ovarian Res
. 2023 Jun;
16(1):110.
PMID: 37277766
Background: The risk of suffering epithelial ovarian cancer (EOC) for women increases with age evidently, while the prognosis of older EOC patients remain unclear. Against the backdrop of the accelerate...
6.
Luo X, Shen Y, Huang W, Bao Y, Mo J, Yao L, et al.
Cancer Control
. 2023 Feb;
30:10732748231159706.
PMID: 36826231
Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing treatments, immunotherapy...
7.
Huang W, Bao Y, Luo X, Yao L, Yuan L
Ann Transl Med
. 2022 Aug;
10(13):728.
PMID: 35957727
Background: Despite high-grade serous ovarian carcinoma (HGSOC) being the most common epithelial ovarian cancer, it is a heterogenous group of tumors with several histological subtypes. The goal of our study...
8.
Bao Y, Huang W, Yao L, Yuan L
Gland Surg
. 2022 Jun;
11(5):932-937.
PMID: 35694095
Background: Endometriosis is a disturbing condition affecting about 10% of all reproductive aged women. The most severe form of endometriosis is deeply infiltrative endometriosis (DIE). Bowel is commonly affected in...
9.
Huang W, Bao Y, Luo X, Yao L, Yuan L
Endocrine
. 2022 May;
77(1):188-198.
PMID: 35538309
Objective: Ovarian neuroendocrine neoplasm is a rare and highly heterogeneous neoplasm. This study is aimed to describe its demographic and clinicopathological features and identify its prognostic factors. Methods: Clinical data...